808
Views
60
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Gastrointestinal stability of dihydromyricetin, myricetin, and myricitrin: an in vitro investigation

, , , , , & show all
Pages 704-711 | Received 19 Jun 2016, Accepted 21 Dec 2016, Published online: 23 Jan 2017

References

  • Asafu-Adjaye EB, Faustino PJ, Tawakkul MA, Anderson LW, Yu LX, Kwon H, Volpe DA. 2007. Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine. J Pharm Biomed Anal. 43:1854–1859.
  • Bohn T. 2014. Dietary factors affecting polyphenol bioavailability. Nutrition Rev. 72:429–452.
  • Chen ML, Shah V, Patnaik R, Adams W, Hussain A, Conner D, Mehta M, Malinowski H, Lazor J, Huang SM, et al. 2001. Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res. 18:1645–1650.
  • Dang Y, Lin G, Xie Y, Duan J, Ma P, Li G, Ji G. 2014. Quantitative determination of myricetin in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its absolute bioavailability. Drug Res (Stuttg). 64:516–522.
  • Devi KP, Rajavel T, Habtemariam S, Nabavi SF, Nabavi SM. 2015. Molecular mechanisms underlying anticancer effects of myricetin. Life Sci. 142:19–25.
  • Domitrovic R, Rashed K, Cvijanovic O, Vladimir-Knezevic S, Skoda M, Visnic A. 2015. Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact. 230:21–29.
  • Fallingborg J. 1999. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull. 46:183–196.
  • Gharibzahedi SM, Razavi SH, Mousavi M. 2014. Characterizing the natural canthaxanthin/2-hydroxypropyl-beta-cyclodextrin inclusion complex. Carbohydr Polym. 101:1147–1153.
  • Gualdesi MS, Esteve-Romero J, Brinon MC, Raviolo MA. 2013. Development and validation of a stability indicating method for seven novel derivatives of lamivudine with anti-HIV and anti-HBV activity in simulated gastric and intestinal fluids. J Pharm Biomed Anal. 78–79:52–56.
  • Hollman PCH. 2004. Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol. 42:74–83.
  • Hou X, Tong Q, Wang W, Xiong W, Shi C, Fang J. 2015. Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways. Life Sci. 130:38–46.
  • Hu M. 2007. Commentary: bioavailability of flavonoids and polyphenols: call to arms. Mol Pharm. 4:803–806.
  • Liu Y, Blumberg JB, Chen CY. 2014. Quantification and bioaccessibility of california pistachio bioactives. J Agric Food Chem. 62:1550–1556.
  • Ma Y, Zeng M, Sun R, Hu M. 2014. Disposition of flavonoids impacts their efficacy and safety. Curr Drug Metabol. 15:841–864.
  • Machu L, Misurcova L, Ambrozova JV, Orsavova J, Mlcek J, Sochor J, Jurikova T. 2015. Phenolic content and antioxidant capacity in algal food products. Molecules. 20:1118–1133.
  • Maggiolini M, Recchia AG, Bonofiglio D, Catalano S, Vivacqua A, Carpino A, Rago V, Rossi R, Ando S. 2005. The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells. J Mol Endocrinol. 35:269–281.
  • Mena P, Dall'asta M, Calani L, Brighenti F, Del RD. Forthcoming 2015. Gastrointestinal stability of urolithins: an in vitro approach. Eur J Nutr. DOI:10.1007/s00394-015-1061-4
  • Merken HM, Merken CD, Beecher GR. 2001. Kinetics method for the quantitation of anthocyanidins, flavonols, and flavones in foods. J Agric Food Chem. 49:2727–2732.
  • Mureşan-Pop M, Chiriac LB, Martin F, Simon S. 2016. Novel nutraceutical Myricetin composite of enhanced dissolution obtained by co-crystallization with acetamide. Compos Part B: Eng. 89:60–66.
  • Ozdal T, Sela DA, Xiao J, Boyacioglu D, Chen F, Capanoglu E. 2016. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients. 8:78.
  • Qi S, Xin Y, Guo Y, Diao Y, Kou X, Luo L, Yin Z. 2012. Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-kappaB signaling pathways. Int Immunopharmacol. 12:278–287.
  • Rubilar M, Morales E, Sáez R, Acevedo F, Palma B, Villarroel M, Shene C. 2012. Polyphenolic fractions improve the oxidative stability of microencapsulated linseed oil. Eur J Lipid Sci Technol. 114:760–771.
  • Shen Y, Lindemeyer AK, Gonzalez C, Shao XM, Spigelman I, Olsen RW, Liang J. 2012. Dihydromyricetin as a novel anti-alcohol intoxication medication. J Neurosci. 32:390–401.
  • Shim S, Yi H, Kim Y. 2011. Bioaccessibility of flavonoids and total phenolic content in onions and its relationship with antioxidant activity. Int J Food Sci Nutr. 62:835–838.
  • Stalmach A, Edwards CA, Wightman JD, Crozier A. 2012. Gastrointestinal stability and bioavailability of (poly)phenolic compounds following ingestion of Concord grape juice by humans. Mol Nutr Food Res. 56:497–509.
  • Tong Q, Hou X, Fang J, Wang W, Xiong W, Liu X, Xie X, Shi C. 2015. Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. J Pharm Biomed Anal. 114:455–461.
  • Wang C, Tong Q, Hou X, Hu S, Fang J, Sun CC. 2016a. Enhancing bioavailability of dihydromyricetin through inhibiting precipitation of soluble cocrystals by a crystallization inhibitor. Cryst Growth Des. 16:5030–5039.
  • Wang C, Xiong W, Perumalla SR, Fang J, Sun CC. 2016b. Solid-state characterization of optically pure (+)Dihydromyricetin extracted from Ampelopsis grossedentata leaves. Int J Pharm. 511:245–252.
  • Yang XL, Yuan ZF, Zhang LT, Fan LF. 2009. Study on the pharmacokinetics of myricitrin, hyperin and quercitroside in the total flavonoids from Rhododendrom micranthum. Chin J Hospital Pharm. 29:1610–1614.
  • Yokomizo A, Moriwaki M. 2005. Myricitrin degraded by simulated digestion inhibits oxidation of human low-density lipoprotein. Biosci Biotechnol Biochem. 69:693–699.
  • Zhang Q, Liu J, Liu B, Xia J, Chen N, Chen X, Cao Y, Zhang C, Lu C, Li M, Zhu R. 2014. Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism. Sci Rep. 4:4628.
  • Zhu X, Jia YH. 2014. Inhibition of catechol-o-methyltransferase (COMT) by myricetin, dihydromyricetin, and myricitrin. Pharmazie. 69:183–186.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.